Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells

Free Radical Biology and Medicine

Volumn 51, Issue 2, 2011, Pages 444-453

  Kesic, Matthew J ^a,b   Simmons, Steven O ^c   Bauer, Rebecca ^a,b   Jaspers, Ilona ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Influenza; Nasal epithelial cells; Nrf2; Viral entry

Indexed keywords

BETA INTERFERON; EPIGALLOCATECHIN GALLATE; LENTIVIRUS VECTOR; MESSENGER RNA; MYXOVIRUS RESISTANCE PROTEIN A; RETINOIC ACID INDUCIBLE PROTEIN I; SHORT HAIRPIN RNA; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2;

ARTICLE; DIET SUPPLEMENTATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA VIRUS A; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ENTRY; VIRUS LIKE AGENT; VIRUS REPLICATION;

BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFLUENZA A VIRUS; MEMBRANE FUSION; NASAL MUCOSA; NF-E2-RELATED FACTOR 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 80955180498     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.04.027     Document Type: Article

References (71)

1. A.S. Monto Occurrence of respiratory virus: time, place and person Pediatr. Infect. Dis. J. 23 2004 S58 S64
2. L.C. Lambert, and A.S. Fauci Influenza vaccines for the future N. Engl. J. Med. 363 2010 2036 2044
3. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, N. Cox, L.J. Anderson, and K. Fukuda Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 2003 179 186 (Pubitemid 36068705)
4. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, C.B. Bridges, N.J. Cox, and K. Fukuda Influenza-associated hospitalizations in the United States JAMA 292 2004 1333 1340 (Pubitemid 39223224)
5. T. Watanabe, S. Watanabe, and Y. Kawaoka Cellular networks involved in the influenza virus life cycle Cell Host Microbe 7 2010 427 439
6. D. Weycker, J. Edelsberg, M.E. Halloran, I.M. Longini Jr., A. Nizam, V. Ciuryla, and G. Oster Population-wide benefits of routine vaccination of children against influenza Vaccine 23 2005 1284 1293 (Pubitemid 40126532)
7. W.P. Glezen Emerging infections: pandemic influenza Epidemiol. Rev. 18 1996 64 76 (Pubitemid 26303555)
8. W.P. Glezen, S.B. Greenberg, R.L. Atmar, P.A. Piedra, and R.B. Couch Impact of respiratory virus infections on persons with chronic underlying conditions JAMA 283 2000 499 505 (Pubitemid 30062866)
9. M.A. Beck Antioxidants and viral infections: host immune response and viral pathogenicity J. Am. Coll. Nutr. 20 2001 384S 388S discussion 396S-397S (Pubitemid 32948017)
10. C.C. Flanigan, and D.H. Sprunt The effect of malnutrition on the susceptibility of the host to viral infection J. Exp. Med. 104 1956 687 706
11. A.G. Smith, P.A. Sheridan, J.B. Harp, and M.A. Beck Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus J. Nutr. 137 2007 1236 1243 (Pubitemid 46701917)
12. M.B. Graham, and T.J. Braciale Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice J. Exp. Med. 186 1997 2063 2068 (Pubitemid 28013692)
13. F.R. Toapanta, and T.M. Ross Impaired immune responses in the lungs of aged mice following influenza infection Respir. Res. 10 2009 112
14. T.L. Noah, H. Zhou, J. Monaco, K. Horvath, M. Herbst, and I. Jaspers Tobacco smoke exposure and altered nasal responses to live attenuated influenza virus Environ. Health Perspect. 119 1 2011 78 83
15. I. Jaspers, J.M. Ciencewicki, W. Zhang, L.E. Brighton, J.L. Carson, M.A. Beck, and M.C. Madden Diesel exhaust enhances influenza virus infections in respiratory epithelial cells Toxicol. Sci. 85 2005 990 1002 (Pubitemid 40846874)
16. I. Jaspers, K.M. Horvath, W. Zhang, L.E. Brighton, J.L. Carson, and T.L. Noah Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza Am. J. Respir. Cell Mol. Biol. 43 2009 368 375
17. H.Y. Cho, F. Imani, L. Miller-DeGraff, D. Walters, G.A. Melendi, M. Yamamoto, F.P. Polack, and S.R. Kleeberger Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease Am. J. Respir. Crit. Care Med. 179 2009 138 150
18. G.J. Jakab, and D.J. Bassett Influenza virus infection, ozone exposure, and fibrogenesis Am. Rev. Respir. Dis. 141 1990 1307 1315 (Pubitemid 20172588)
19. S. Razani-Boroujerdi, S.P. Singh, C. Knall, F.F. Hahn, J.C. Pena-Philippides, R. Kalra, R.J. Langley, and M.L. Sopori Chronic nicotine inhibits inflammation and promotes influenza infection Cell. Immunol. 230 2004 1 9 (Pubitemid 39482356)
20. H.Y. Cho, and S.R. Kleeberger Nrf2 protects against airway disorders Toxicol. Appl. Pharmacol. 244 2010 43 56
21. Y.H. Kim, A. Coon, A.F. Baker, and G. Powis Antitumor agent PX-12 inhibits HIF-1alpha protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase Cancer Chemother. Pharmacol. 2010 10.1007/s00280-010-1500-0
22. I. Rahman Antioxidant therapeutic advances in COPD Ther. Adv. Respir. Dis. 2 2008 351 374
23. D. Jia, R. Rahbar, R.W. Chan, S.M. Lee, M.C. Chan, B.X. Wang, D.P. Baker, B. Sun, J.S. Peiris, J.M. Nicholls, and E.N. Fish Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling PLoS One 5 2010 e13927
24. S. Chen, J.A. Short, D.F. Young, M.J. Killip, M. Schneider, S. Goodbourn, and R.E. Randall Heterocellular induction of interferon by negative-sense RNA viruses Virology 407 2010 247 255
25. D. Jia, R. Rahbar, R.W. Chan, S.M. Lee, M.C. Chan, B.X. Wang, D.P. Baker, B. Sun, J.S. Peiris, J.M. Nicholls, and E.N. Fish Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling PLoS One 5 2010 e13927
26. O. Haller, and G. Kochs Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity Traffic 3 2002 710 717
27. H. Zhou, X. Wang, L. Brighton, M. Hazucha, I. Jaspers, and J.L. Carson Increased nasal epithelial ciliary beat frequency associated with lifestyle tobacco smoke exposure Inhal. Toxicol. 21 2009 875 881
28. R.R. Reddel, Y. Ke, B.I. Gerwin, M.G. McMenamin, J.F. Lechner, R.T. Su, D.E. Brash, J.B. Park, J.S. Rhim, and C.C. Harris Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes Cancer Res. 48 1988 1904 1909
29. H. Niwa, K. Yamamura, and J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 1991 193 199
30. M. Quinlivan, D. Zamarin, A. Garcia-Sastre, A. Cullinane, T. Chambers, and P. Palese Attenuation of equine influenza viruses through truncations of the NS1 protein J. Virol. 79 2005 8431 8439 (Pubitemid 40853545)
31. G. Neumann, T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D.R. Perez, R. Donis, and E. Hoffmann Generation of influenza A viruses entirely from cloned cDNAs Proc. Natl Acad. Sci. U. S. A. 96 1999 9345 9350 (Pubitemid 29374757)
32. B. Manicassamy, and L. Rong Expression of Ebolavirus glycoprotein on the target cells enhances viral entry Virol. J. 6 2009 75
33. G.A. Marsh, R. Hatami, and P. Palese Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions J. Virol. 81 2007 9727 9736 (Pubitemid 350067677)
34. I. Jaspers, W. Zhang, L.E. Brighton, J.L. Carson, M. Styblo, and M.A. Beck Selenium deficiency alters epithelial cell morphology and responses to influenza Free Radic. Biol. Med. 42 2007 1826 1837 (Pubitemid 46754759)
35. F.I. Farag-Mahmod, P.R. Wyde, J.P. Rosborough, and H.R. Six Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice Vaccine 6 1988 262 268
36. T. Nguyen, P.J. Sherratt, H.C. Huang, C.S. Yang, and C.B. Pickett Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome J. Biol. Chem. 278 2003 4536 4541 (Pubitemid 36800950)
37. S. Nair, A. Barve, T.O. Khor, G.X. Shen, W. Lin, J.Y. Chan, L. Cai, and A.N. Kong Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells Acta Pharmacol. Sin. 31 2010 1223 1240
38. Y. Shinkai, D. Sumi, I. Fukami, T. Ishii, and Y. Kumagai Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes FEBS Lett. 580 2006 1771 1774
39. D.M. Tscherne, B. Manicassamy, and A. Garcia-Sastre An enzymatic virus-like particle assay for sensitive detection of virus entry J. Virol. Methods 163 2010 336 343
40. H.Y. Cho, S.P. Reddy, and S.R. Kleeberger Nrf2 defends the lung from oxidative stress Antioxid. Redox Signal. 8 2006 76 87 (Pubitemid 43324533)
41. K. Zhang, H. Yang, Y. Wang, L. Ma, and Q. Zhou Expression and significance of nrf2 and its target genes in pulmonary adenocarcinoma a549 cells resistant to cisplatin Zhongguo Fei Ai Za Zhi 12 2009 1150 1154
42. U. Florczyk, A. Loboda, A. Stachurska, A. Jozkowicz, and J. Dulak Role of Nrf2 transcription factor in cellular response to oxidative stress Postepy Biochem. 56 2010 147 155
43. C.S. Robbins, C.M. Bauer, N. Vujicic, G.J. Gaschler, B.D. Lichty, E.G. Brown, and M.R. Stampfli Cigarette smoke impacts immune inflammatory responses to influenza in mice Am. J. Respir. Crit. Care Med. 174 2006 1342 1351 (Pubitemid 44913036)
44. M. Cavrois, C. De Noronha, and W.C. Greene A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes Nat. Biotechnol. 20 2002 1151 1154 (Pubitemid 35285446)
45. A. Yonezawa, M. Cavrois, and W.C. Greene Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha J. Virol. 79 2005 918 926 (Pubitemid 40053875)
46. A. Shulla, T. Heald-Sargent, G. Subramanya, J. Zhao, S. Perlman, and T. Gallagher A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry J. Virol. 85 2011 873 882
47. S. Matsuyama, N. Nagata, K. Shirato, M. Kawase, M. Takeda, and F. Taguchi Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2 J. Virol. 84 2010 12658 12664
48. K. Chandran, N.J. Sullivan, U. Felbor, S.P. Whelan, and J.M. Cunningham Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection Science 308 2005 1643 1645 (Pubitemid 40807517)
49. S. Matsuyama, and F. Taguchi Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis J. Virol. 83 2009 11133 11141
50. G. Simmons, J.D. Reeves, A.J. Rennekamp, S.M. Amberg, A.J. Piefer, and P. Bates Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry Proc. Natl Acad. Sci. U. S. A. 101 2004 4240 4245 (Pubitemid 38405913)
51. E. Bottcher, T. Matrosovich, M. Beyerle, H.D. Klenk, W. Garten, and M. Matrosovich Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium J. Virol. 80 2006 9896 9898 (Pubitemid 44435664)
52. T. Iizuka, Y. Ishii, K. Itoh, T. Kiwamoto, T. Kimura, Y. Matsuno, Y. Morishima, A.E. Hegab, S. Homma, and A. Nomura Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema Genes Cells 10 2005 1113 1125 (Pubitemid 41830071)
53. S. Yasuoka, T. Ohnishi, S. Kawano, S. Tsuchihashi, M. Ogawara, K. Masuda, K. Yamaoka, M. Takahashi, and T. Sano Purification, characterization, and localization of a novel trypsin-like protease found in the human airway Am. J. Respir. Cell Mol. Biol. 16 1997 300 308 (Pubitemid 127497453)
54. R. Szabo, and T.H. Bugge Type II transmembrane serine proteases in development and disease Int. J. Biochem. Cell Biol. 40 2008 1297 1316
55. J. Pavlovic, T. Zurcher, O. Haller, and P. Staeheli Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein J. Virol. 64 1990 3370 3375 (Pubitemid 20219541)
56. M. Schlee, and G. Hartmann The chase for the RIG-I ligand-recent advances Mol. Ther. 18 2010 1254 1262
57. M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Nat. Immunol. 5 2004 730 737 (Pubitemid 39023305)
58. C.T. Ranjith-Kumar, Y. Lai, R.T. Sarisky, and C. Cheng Kao Green tea catechin, epigallocatechin gallate, suppresses signaling by the dsRNA innate immune receptor RIG-I PLoS One 5 2010 e12878
59. H.Y. Cho, S.P. Reddy, A. Debiase, M. Yamamoto, and S.R. Kleeberger Gene expression profiling of NRF2-mediated protection against oxidative injury Free Radic. Biol. Med. 38 2005 325 343 (Pubitemid 40081112)
60. H.K. Na, E.H. Kim, J.H. Jung, H.H. Lee, J.W. Hyun, and Y.J. Surh (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells Arch. Biochem. Biophys. 476 2008 171 177
61. C.E. Guerrero-Beltran, M. Calderon-Oliver, J. Pedraza-Chaverri, and Y.I. Chirino Protective effect of sulforaphane against oxidative stress: recent advances Exp. Toxicol. Pathol. 2010 10.1016/j.etp.2010.11.005
62. S.B. Wan, K.R. Landis-Piwowar, D.J. Kuhn, D. Chen, Q.P. Dou, and T.H. Chan Structure-activity study of epi-gallocatechin gallate (EGCG) analogs as proteasome inhibitors Bioorg. Med. Chem. 13 2005 2177 2185 (Pubitemid 40261137)
63. M. Zhu, Y. Chen, and R.C. Li Oral absorption and bioavailability of tea catechins Planta Med. 66 2000 444 447 (Pubitemid 30413506)
64. C.C. Wu, M.C. Hsu, C.W. Hsieh, J.B. Lin, P.H. Lai, and B.S. Wung Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways Life Sci. 78 2006 2889 2897
65. M. Nakayama, K. Suzuki, M. Toda, S. Okubo, Y. Hara, and T. Shimamura Inhibition of the infectivity of influenza virus by tea polyphenols Antiviral Res. 21 1993 289 299 (Pubitemid 23231550)
66. J.-M. Song, K.-H. Lee, and B.-L. Seong Antiviral effect of catechins in green tea on influenza virus Antiviral Res. 68 2005 66 74 (Pubitemid 41565520)
67. J.M. Marzec, J.D. Christie, S.P. Reddy, A.E. Jedlicka, H. Vuong, P.N. Lanken, R. Aplenc, T. Yamamoto, M. Yamamoto, H.Y. Cho, and S.R. Kleeberger Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury FASEB J. 21 2007 2237 2246 (Pubitemid 47026458)
68. J.E. Repine Scientific perspectives on adult respiratory distress syndrome Lancet 339 1992 466 469
69. M.L. Hernandez, J.C. Lay, B. Harris, C.R. Esther Jr., W.J. Brickey, P.A. Bromberg, D. Diaz-Sanchez, R.B. Devlin, S.R. Kleeberger, N.E. Alexis, and D.B. Peden Atopic asthmatic subjects but not atopic subjects without asthma have enhanced inflammatory response to ozone J. Allergy Clin. Immunol. 126 2010 537-544 e531
70. L. Ye, A.T. Dinkova-Kostova, K.L. Wade, Y. Zhang, T.A. Shapiro, and P. Talalay Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans Clin. Chim. Acta 316 2002 43 53 (Pubitemid 34028187)
71. J.M. Van Amelsvoort, K.H. Van Hof, J.N. Mathot, T.P. Mulder, A. Wiersma, and L.B. Tijburg Plasma concentrations of individual tea catechins after a single oral dose in humans Xenobiotica 31 2001 891 901 (Pubitemid 34074791)